Physiotherapy Protocol in Treating Chronic Rhinosinusitis
Effect of Adding Physiotherapy Program to the Conservative Medical Therapy on Quality of Life and Pain Threshold in Chronic Rhinosinusitis Patients: A Prospective Randomized Controlled Trial
1 other identifier
interventional
68
1 country
1
Brief Summary
This study aims to investigate the effect of adding of integrated physiotherapy program to the conservative medical therapy on quality of life and pressure pain threshold (PPT) in chronic rhinosinusitis patients. Patients in this study will be randomly assigned into 2 groups. Group A (control group) will receive conservative medical treatment only which prescribed by Ear, Nose and Throat (ENT) specialist, while group B (experimental group) will receive the conservative medical treatment prescribed by ENT specialist in addition to physiotherapy program. Quality of Life (QoL) will be evaluated by Rhinosinusitis Disability Index (RSDI) and PPT will be evaluated by digital algometer at the baseline and immediately after the end of tenth session of treatment for both groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2022
CompletedFirst Posted
Study publicly available on registry
July 5, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2023
CompletedOctober 26, 2023
October 1, 2023
6 months
June 26, 2022
October 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rhinosinusitis Disability Index (RSDI)
Arabic version of Rhinosinusitis Disability Index will be used to assess the change in quality of life
From baseline to 4 weeks after treatment (immediately after the completion of session 12)
Secondary Outcomes (1)
Pressure pain threshold
From baseline to 4 weeks after treatment (immediately after the completion of session 12)
Study Arms (2)
Conservative medical therapy
NO INTERVENTIONPatients in this group received only medication prescribed by an Ear, Nose and Throat specialist.
Medication and Physiotherapy program
EXPERIMENTALPatients in this group received medication prescribed by an Ear, Nose and Throat specialist, in addition to integrated Physiotherapy program
Interventions
Using an Enraf Nonius Sonoplus 490 from the Netherlands, the patients were asked to lie supine while the therapist stood at the level of the patient's head. The patients received pulsed (duty cycle 50%) US therapy with intensities of 1 and 0.5 W/cm2 for maxillary and frontal sinus, respectively, and a collimating beam frequency of 1MHz. To deliver US to the treatment area, a small probe US applicator (0.8 cm2) with an effective radiating area (ERA) of 0.6 cm2 and a beam non-uniformity ratio (BNR) of 6:1 was used. The skin around the cheeks was used for the maxillary sinus and the forehead for the frontal sinus. Between the applicator and the skin, ultrasound transmission gel was employed, and a full contact technique in slow circular motion was used for 5 minutes over the maxillary sinuses and 4 minutes over the frontal sinuses on each pair of sinuses
Manual Drainage Techniques for the frontal and maxillary sinuses
Patients will also encouraged to self-massage their frontal and maxillary sinuses while resting supine
Eligibility Criteria
You may qualify if:
- Patients of both sexes
- Aged from 30 to 50 years
- Cynically diagnosed by Ear, Nose, and Throat (ENT) specialist, with chronic rhinosinusitis with a history of more than 3 months, confirmed by clinical diagnostic criteria (more than or equal to two major symptoms or one major symptom (nasal obstruction, facial pain/pressure, postnasal drip and hyposmia) and two minor symptoms (headache, halitosis, fatigue, dental pain and ear pain) and also verified by Computed Tomography (CT) scan results .
You may not qualify if:
- Having any tumors or cysts (as confirmed by CT scan)
- Nasal polyps
- Facial skin lesions or diseases or allergies of the face
- Pregnancy
- Metal implants in the face region
- Previous nasal surgical procedures
- Impaired thermal sensation (such as uncontrolled diabetes mellitus)
- Cognitive level impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
- Jouf Universitycollaborator
Study Sites (1)
Al Qurayyat General Hospital
Qurayyat, Jouf Region, 77471, Saudi Arabia
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Khaled Fouda, PhD
Associate Professor of Physical Therapy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Physical therapy
Study Record Dates
First Submitted
June 26, 2022
First Posted
July 5, 2022
Study Start
September 1, 2022
Primary Completion
March 1, 2023
Study Completion
March 21, 2023
Last Updated
October 26, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- The dead time for IPD will be 30 June.2025
- Access Criteria
- will be uploaded on the official site of CTR
The IPD will be shared including a summary of the results after the study completion date.